UTICA — ConMed Corp. (NASDAQ: CNMD), a Utica–based surgical-device maker, recently announced that its board of directors has declared a cash dividend of 20 cents a share for the latest quarter. The dividend is payable on Jan. 5 to all shareholders of record as of Dec. 15, according to a company news release. At its […]
UTICA — ConMed Corp. (NASDAQ: CNMD), a Utica–based surgical-device maker, recently announced that its board of directors has declared a cash dividend of 20 cents a share for the latest quarter.
The dividend is payable on Jan. 5 to all shareholders of record as of Dec. 15, according to a company news release.
At its current stock price, the dividend yields 1.5 percent on an annual basis.
ConMed specializes in surgical devices and equipment for minimally invasive procedures. The company’s products are used by surgeons and physicians in specialties including orthopedics, general surgery, gynecology, neurosurgery, and gastroenterology.
The firm has a direct selling presence in 17 countries and international sales account for about half of its total sales. Headquartered in Utica, ConMed employs about 3,300 people worldwide.
ConMed generated total sales of $190.1 million in the third quarter, up nearly 3 percent from the year-ago period. The company reported net income of $7.2 million in the third quarter, down slightly from $7.3 million a year prior.
Post
Share
Tweet
Print
Email
Get our email updates
Stay up-to-date on the companies, people and issues that impact businesses in Syracuse, Central New York and beyond.
UTICA — ConMed Corp. (NASDAQ: CNMD), a Utica–based surgical-device maker, recently announced that its board of directors has declared a cash dividend of 20 cents a share for the latest quarter.
The dividend is payable on Jan. 5 to all shareholders of record as of Dec. 15, according to a company news release.
At its current stock price, the dividend yields 1.5 percent on an annual basis.
ConMed specializes in surgical devices and equipment for minimally invasive procedures. The company’s products are used by surgeons and physicians in specialties including orthopedics, general surgery, gynecology, neurosurgery, and gastroenterology.
The firm has a direct selling presence in 17 countries and international sales account for about half of its total sales. Headquartered in Utica, ConMed employs about 3,300 people worldwide.
ConMed generated total sales of $190.1 million in the third quarter, up nearly 3 percent from the year-ago period. The company reported net income of $7.2 million in the third quarter, down slightly from $7.3 million a year prior.
" />
UTICA — ConMed Corp. (NASDAQ: CNMD), a Utica–based surgical-device maker, recently announced that its board of directors has declared a cash dividend of 20 cents a share for the latest quarter. The dividend is payable on Jan. 5 to all shareholders of record as of Dec. 15, according to a company news release. At its […]
UTICA — ConMed Corp. (NASDAQ: CNMD), a Utica–based surgical-device maker, recently announced that its board of directors has declared a cash dividend of 20 cents a share for the latest quarter.
The dividend is payable on Jan. 5 to all shareholders of record as of Dec. 15, according to a company news release.
At its current stock price, the dividend yields 1.5 percent on an annual basis.
ConMed specializes in surgical devices and equipment for minimally invasive procedures. The company’s products are used by surgeons and physicians in specialties including orthopedics, general surgery, gynecology, neurosurgery, and gastroenterology.
The firm has a direct selling presence in 17 countries and international sales account for about half of its total sales. Headquartered in Utica, ConMed employs about 3,300 people worldwide.
ConMed generated total sales of $190.1 million in the third quarter, up nearly 3 percent from the year-ago period. The company reported net income of $7.2 million in the third quarter, down slightly from $7.3 million a year prior.
